Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia - PubMed (original) (raw)

Comparative Study

. 2007 Sep;102(6):2008-2019.

doi: 10.1111/j.1471-4159.2007.04677.x. Epub 2007 Jun 7.

Affiliations

• PMID: 17555556
• DOI: 10.1111/j.1471-4159.2007.04677.x

Free article

Comparative Study

Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia

Qin Xiao et al. J Neurochem. 2007 Sep.

Free article

Abstract

Recent studies suggest that microglia over-expressing mutant human superoxide dismutase (mSOD1(G93A)) may contribute to motoneuron death in a transgenic mouse model of familial amyotrophic lateral sclerosis. To further assess the relative neurotoxicity of wild-type microglia, mSOD1(G93A) microglia, and microglia over-expressing wild-type human SOD1, we used primary cultures of microglia and motoneurons in the presence and absence of lipopolysaccharide stimulation. Following activation with lipopolysaccharide, mSOD1(G93A) microglia released more nitric oxide, more superoxide, and less insulin-like growth factor-1 than wild-type microglia. In microglia/motoneuron co-cultures, mSOD1(G93A) microglia induced more motoneuron death and decreased neurite numbers and length compared with wild-type microglia. Mutant SOD1(G93A) microglia also induced more motoneuron injury than microglia over-expressing wild-type human SOD1 in microglia/motoneuron co-cultures. Motoneuron survival was inversely correlated with nitrate + nitrite concentrations in mSOD1(G93A) co-cultures, suggesting the important role of nitric oxide in microglia-induced motoneuron injury. Thus, relative to wild-type microglia, mSOD1(G93A) microglia were more neurotoxic and induced more motoneuron injury than similarly treated wild-type microglia.

PubMed Disclaimer

Similar articles

• Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.
  Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH. Beers DR, et al. Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16021-6. doi: 10.1073/pnas.0607423103. Epub 2006 Oct 16. Proc Natl Acad Sci U S A. 2006. PMID: 17043238 Free PMC article.
• Extracellular mutant SOD1 induces microglial-mediated motoneuron injury.
  Zhao W, Beers DR, Henkel JS, Zhang W, Urushitani M, Julien JP, Appel SH. Zhao W, et al. Glia. 2010 Jan 15;58(2):231-43. doi: 10.1002/glia.20919. Glia. 2010. PMID: 19672969 Free PMC article.
• Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
  Jaarsma D, Haasdijk ED, Grashorn JA, Hawkins R, van Duijn W, Verspaget HW, London J, Holstege JC. Jaarsma D, et al. Neurobiol Dis. 2000 Dec;7(6 Pt B):623-43. doi: 10.1006/nbdi.2000.0299. Neurobiol Dis. 2000. PMID: 11114261
• The microglial-motoneuron dialogue in ALS.
  Appel SH, Zhao W, Beers DR, Henkel JS. Appel SH, et al. Acta Myol. 2011 Jun;30(1):4-8. Acta Myol. 2011. PMID: 21842586 Free PMC article. Review.
• Microglia in ALS: the good, the bad, and the resting.
  Henkel JS, Beers DR, Zhao W, Appel SH. Henkel JS, et al. J Neuroimmune Pharmacol. 2009 Dec;4(4):389-98. doi: 10.1007/s11481-009-9171-5. J Neuroimmune Pharmacol. 2009. PMID: 19731042 Review.

Cited by

• Combination AAV therapy with galectin-1 and SOD1 downregulation demonstrates superior therapeutic effect in a severe ALS mouse model.
  Baird MC, Likhite SB, Vetter TA, Caporale JR, Girard HB, Roussel FS, Howard AE, Schwartz MK, Reed AR, Kaleem A, Zhang X, Meyer KC. Baird MC, et al. Mol Ther Methods Clin Dev. 2024 Aug 6;32(3):101312. doi: 10.1016/j.omtm.2024.101312. eCollection 2024 Sep 12. Mol Ther Methods Clin Dev. 2024. PMID: 39257530 Free PMC article.
• Frequency and Focus of in Vitro Studies of Microglia-Expressed Cytokines in Response to Viral Infection: A Systematic Review.
  Barrios-González DA, Philibert-Rosas S, Martínez-Juárez IE, Sotelo-Díaz F, Rivas-Alonso V, Sotelo J, Sebastián-Díaz MA. Barrios-González DA, et al. Cell Mol Neurobiol. 2024 Feb 13;44(1):21. doi: 10.1007/s10571-024-01454-9. Cell Mol Neurobiol. 2024. PMID: 38349562 Free PMC article. Review.
• Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential.
  You J, Youssef MMM, Santos JR, Lee J, Park J. You J, et al. Biology (Basel). 2023 Oct 3;12(10):1307. doi: 10.3390/biology12101307. Biology (Basel). 2023. PMID: 37887017 Free PMC article. Review.
• Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets.
  Gao C, Jiang J, Tan Y, Chen S. Gao C, et al. Signal Transduct Target Ther. 2023 Sep 22;8(1):359. doi: 10.1038/s41392-023-01588-0. Signal Transduct Target Ther. 2023. PMID: 37735487 Free PMC article. Review.
• The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis.
  He D, Xu Y, Liu M, Cui L. He D, et al. Aging Dis. 2024 Feb 1;15(1):96-114. doi: 10.14336/AD.2023.0519. Aging Dis. 2024. PMID: 37307819 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal